Case report and review of literature on osteogenesis imperfecta caused by a new mutation of COL1A2 in neonates

CHENG Fei, ZHOU Jun-min

Chinese Journal of Child Health Care ›› 2019, Vol. 27 ›› Issue (2) : 216-218.

PDF(1444 KB)
PDF(1444 KB)
Chinese Journal of Child Health Care ›› 2019, Vol. 27 ›› Issue (2) : 216-218. DOI: 10.11852/zgetbjzz2018-0351

Case report and review of literature on osteogenesis imperfecta caused by a new mutation of COL1A2 in neonates

  • CHENG Fei, ZHOU Jun-min
Author information +
History +

Abstract

Objective To analyze and summarize the clinical phenotype and gene mutation characteristics of a de novo COL1A2 gene mutation in a newborn with osteogenesis imperfecta (OI),in order to improve the diagnosis and understanding of OI. Methods Clinical data and test results were reviewed from a newborn diagnosed with OI in the department of Pediatrics of the Third Hospital of Xiamen Affiliated Hospital in August 2017. In addition, the newborn and her parents′ peripheral blood genomic DNA were extracted, and the genes related to OI were analyzed and reviewed by using the whole-sequence exon gene detection technology. Results The patient′s COL1A1 gene was not found with pathogenicity variation, while the COL1A2 gene was detected with a new hybrid missense mutation (c.G2882A, p.G961D). The mutation had not been reported in PubMed and HGMD databases, which was inherited from her mother. Conclusions According to the clinical information of the children, the genetic model of disease and comprehensive evaluation of Exomiser software, it is predicted that the new mutation of COL1A2 gene (c.G2882A, p.G961D) is the cause of OI in this case.

Key words

osteogenesis imperfecta / COL1A2 gene / new mutation

Cite this article

Download Citations
CHENG Fei, ZHOU Jun-min. Case report and review of literature on osteogenesis imperfecta caused by a new mutation of COL1A2 in neonates[J]. Chinese Journal of Child Health Care. 2019, 27(2): 216-218 https://doi.org/10.11852/zgetbjzz2018-0351

References

[1] Forlino A, Marini JC.Osteogenesis imperfecta[J]. Lancet,2016,387(10028):1657-1671.
[2] 余长缨,王午喜,韩德宣.成骨不全的诊治进展[J]. 中国儿童保健杂志,2014,22(2):156-158.
[3] Forlino A, Cabral WA, Barnes AM, et al.New perspectives on osteogenesis imperfecta[J]. Nat Rev Endocrinol,2011,7(9):540-557.
[4] 鲁艳芹, 任秀智,王延宙, 等.成骨不全及其分子机制[J]. 生物化学与生物物理进展,2015,42(6):511-518.
[5] Glorieux FH.Osteogenesis imperfecta[J]. Best Pract Res Clin Rheumatol,2008,22(1):85-100.
[6] Marini JC, Forlino A, Cabral WA, et al.Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen:regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans[J]. Hum Mutat,2007,28(3):209-221.
[7] Steiner RD, Adsit J, Basel D.COL1A1/2-related osteogenesis imperfecta[M].//Adam MP, Ardinger HH, Pagon RA, et al. Gene Reviews,Seattle(WA):University of Washington,1993-2018.
[8] 郑峰.成骨不全家系分析并文献复习[J]. 中国全科医学,2012, 15(2):536-537.
[9] 吕芳, 李梅.成骨不全症治疗新药研究进展[J]. 国际药学研究杂志,2017, 44(2):173-176.
[10] Pereira R, Halford K, Sokolov BP,et al.Phenotypic variability and incomplete penetrance of spontaneous fractures in an inbred strain of transgenic mice expressing a mutated collagen gene[J]. J Clin Invest, 1994, 93(4):1765-1769.
PDF(1444 KB)

Accesses

Citation

Detail

Sections
Recommended

/